Intestinal Microbiota Transplant (IMT) Capsules

Developed for: cardiovascular disorder
Investigated by: Nanjing Medical University · Shanghai East Hospital of Tongji University · The First Affiliated Hospital of Guangzhou Medical University · West China Hospital

202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
—	NCT04444362	Jan 2025 → Dec 2026 expected	cardiovascular disorder	Nanjing Medical University	Enrolling by invitation	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Intestinal Microbiota Transplant (IMT) Capsules	ClinicalTrials.gov intervention name — accepted as the source's own label NCT04444362 ↗